57 related articles for article (PubMed ID: 8960564)
1. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase.
Creemer LC; Kirst HA; Vlahos CJ; Schultz RM
J Med Chem; 1996 Dec; 39(25):5021-4. PubMed ID: 8960564
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs.
Norman BH; Shih C; Toth JE; Ray JE; Dodge JA; Johnson DW; Rutherford PG; Schultz RM; Worzalla JF; Vlahos CJ
J Med Chem; 1996 Mar; 39(5):1106-11. PubMed ID: 8676346
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin.
Schultz RM; Merriman RL; Andis SL; Bonjouklian R; Grindey GB; Rutherford PG; Gallegos A; Massey K; Powis G
Anticancer Res; 1995; 15(4):1135-9. PubMed ID: 7653991
[TBL] [Abstract][Full Text] [Related]
4. Effects of wortmannin analogs on bone in vitro and in vivo.
Sato M; Bryant HU; Dodge JA; Davis H; Matter WF; Vlahos CJ
J Pharmacol Exp Ther; 1996 Apr; 277(1):543-50. PubMed ID: 8613966
[TBL] [Abstract][Full Text] [Related]
5. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Powis G; Bonjouklian R; Berggren MM; Gallegos A; Abraham R; Ashendel C; Zalkow L; Matter WF; Dodge J; Grindey G
Cancer Res; 1994 May; 54(9):2419-23. PubMed ID: 8162590
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of fluorescent derivatives of wortmannin and demethoxyviridin as probes for phosphatidylinositol 3-kinase.
Giner JL; Kehbein KA; Cook JA; Smith MC; Vlahos CJ; Badwey JA
Bioorg Med Chem Lett; 2006 May; 16(9):2518-21. PubMed ID: 16464575
[TBL] [Abstract][Full Text] [Related]
7. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
8. Different pathways of inhibitory effects of wortmannin on exocytosis are revealed by video-enhanced light microscope.
Ozawa K; Masujima T; Ikeda K; Kodama Y; Nonomura Y
Biochem Biophys Res Commun; 1996 May; 222(2):243-8. PubMed ID: 8670190
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase inhibitor wortmannin blocks mitogenic activation of the transferrin receptor gene promoter in late G1.
Miskimins WK; King F; Miskimins R
Cell Growth Differ; 1997 May; 8(5):565-70. PubMed ID: 9149907
[TBL] [Abstract][Full Text] [Related]
10. Advances with phospholipid signalling as a target for anticancer drug development.
Powis G; Berggren M; Gallegos A; Frew T; Hill S; Kozikowski A; Bonjouklian R; Zalkow L; Abraham R; Ashendel C
Acta Biochim Pol; 1995; 42(4):395-403. PubMed ID: 8852330
[TBL] [Abstract][Full Text] [Related]
11. Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks antigen-mediated, but not CD3 monoclonal antibody-induced, activation of murine CD4+ T cells.
Shi J; Cinek T; Truitt KE; Imboden JB
J Immunol; 1997 May; 158(10):4688-95. PubMed ID: 9144481
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor stimulation of phosphatidylinositol 3-kinase during wound closure in rabbit corneal epithelial cells.
Zhang Y; Akhtar RA
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1139-48. PubMed ID: 9152233
[TBL] [Abstract][Full Text] [Related]
13. Involvement of stress-activated protein kinase in the cellular response to 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents.
Saleem A; Datta R; Yuan ZM; Kharbanda S; Kufe D
Cell Growth Differ; 1995 Dec; 6(12):1651-8. PubMed ID: 9019171
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin.
Wipf P; Minion DJ; Halter RJ; Berggren MI; Ho CB; Chiang GG; Kirkpatrick L; Abraham R; Powis G
Org Biomol Chem; 2004 Jul; 2(13):1911-20. PubMed ID: 15227545
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of insulin receptor substrate-1 and activation of the PI-3-kinase pathway by glycine-extended gastrin precursors.
Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C
Biochem Biophys Res Commun; 1997 Jul; 236(3):687-92. PubMed ID: 9245714
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of EGF and amphiregulin on adhesion molecule expression and migration of colon carcinoma cells.
Solic N; Davies DE
Exp Cell Res; 1997 Aug; 234(2):465-76. PubMed ID: 9260917
[TBL] [Abstract][Full Text] [Related]
17. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
19. A multiwell assay for inhibitors of phosphatidylinositol-3-kinase and the identification of natural product inhibitors.
Frew T; Powis G; Berggren M; Abraham RT; Ashendel CL; Zalkow LH; Hudson C; Qazia S; Gruszecka-Kowalik E; Merriman R
Anticancer Res; 1994; 14(6B):2425-8. PubMed ID: 7872663
[TBL] [Abstract][Full Text] [Related]
20. Prosaposin: a new player in cell death prevention of U937 monocytic cells.
Misasi R; Garofalo T; Di Marzio L; Mattei V; Gizzi C; Hiraiwa M; Pavan A; Grazia Cifone M; Sorice M
Exp Cell Res; 2004 Aug; 298(1):38-47. PubMed ID: 15242760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
